Peptides for Weight Control
This category covers incretin-agonist peptides — compounds that in research act on receptors regulating appetite and glucose metabolism. It's one of the most actively studied areas of peptide pharmacology right now.
A triple incretin receptor agonist
Retatrutide is a peptide that acts simultaneously on the GIP, GLP-1, and glucagon receptors. Unlike compounds acting on only one of these receptors, this "triple" mechanism is being studied as a way to influence energy metabolism more strongly by combining several appetite- and energy-expenditure-regulating pathways at once.
What matters before starting a protocol
Incretin agonists are an actively researched but also fast-moving class: new data on tolerability profile and dosing appears in the research literature regularly. Any protocol in this category should be discussed with a doctor if it involves actual use rather than just reading the literature — compounds in this class have a noticeable effect on metabolism.
What to consider
- Retatrutide acts on three receptors at once (GIP, GLP-1, glucagon)
- The incretin-agonist class evolves quickly — keep up with new data
- Metabolic impact is significant — discuss any protocol with a doctor
- Temperature-controlled storage is required
Exact prices, dosages, and availability are in the Telegram catalog.
Open in Telegram